文献速递血栓与止血

肿瘤表达的凝血因子VII与乳腺癌生存相关并调控肿瘤进展

Tumor-expressed factor VII is associated with survival and regulates tumor progression in breast cancer.
PubMed 文献 · Blood Adv · 2023-01-01

该研究探讨肿瘤表达的凝血因子VII(FVII)在乳腺癌中的作用。发现乳腺癌标本中FVII水平升高且与肿瘤进展和肝转移相关,肿瘤表达的FVII驱动上皮间质转化(EMT)、侵袭及促转移基因SNAI2和SOX9表达,体内增强肿瘤生长和肝转移,而肝来源FVII似乎抑制转移。肿瘤表达FVII的促转移基因表达不依赖组织因子(TF)但需要功能性内皮蛋白C受体,重组活化FVII通过经典TF:PAR2通路抑制促转移基因表达。作者提出肿瘤表达FVII与肝来源FVII对EMT和转移有相反作用。

要点

  • 乳腺癌标本中FVII水平升高,与肿瘤进展和肝转移相关。
  • 肿瘤表达的FVII驱动EMT、侵袭及促转移基因SNAI2和SOX9表达,体内增强肿瘤生长和肝转移。
  • 肝来源FVII似乎抑制转移,与肿瘤表达FVII作用相反。

核心结论

  • 肿瘤表达的FVII与肝来源FVII对EMT和转移有相反作用。

研究设计与样本

  • 研究采用乳腺癌标本、乳腺癌细胞系及体内实验,探讨肿瘤表达的FVII对肿瘤进展和转移的作用。

主要发现

  • 乳腺癌标本中FVII水平升高,与肿瘤进展和肝转移相关。
  • 乳腺癌细胞系中肿瘤表达的FVII驱动EMT样改变、肿瘤细胞侵袭及促转移基因SNAI2和SOX9表达。
  • 体内实验中肿瘤表达的FVII增强肿瘤生长和肝转移,而肝来源FVII似乎抑制转移。
  • 肿瘤表达FVII诱导促转移基因表达不依赖TF但需要功能性内皮蛋白C受体,重组活化FVII通过经典TF:PAR2通路抑制促转移基因表达。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Cancer enhances the risk of venous thromboembolism, but a hypercoagulant microenvironment also promotes cancer progression. Although anticoagulants have been suggested as a potential anticancer treatment, clinical studies on the effect of such modalities on cancer progression have not yet been successful for unknown reasons. In normal physiology, complex formation between the subendothelial-expressed tissue factor (TF) and the blood-borne liver-derived factor VII (FVII) results in induction of the extrinsic coagulation cascade and intracellular signaling via protease-activated receptors (PARs). In cancer, TF is overexpressed and linked to poor prognosis. Here, we report that increased levels of FVII are also observed in breast cancer specimens and are associated with tumor progression and metastasis to the liver. In breast cancer cell lines, tumor-expressed FVII drives changes reminiscent of epithelial-to-mesenchymal transition (EMT), tumor cell invasion, and expression of the prometastatic genes, SNAI2 and SOX9. In vivo, tumor-expressed FVII enhanced tumor growth and liver metastasis. Surprisingly, liver-derived FVII appeared to inhibit metastasis. Finally, tumor-expressed FVII-induced prometastatic gene expression independent of TF but required a functional endothelial protein C receptor, whereas recombinant activated FVII acting via the canonical TF:PAR2 pathway inhibited prometastatic gene expression. Here, we propose that tumor-expressed FVII and liver-derived FVII have opposing effects on EMT and metastasis.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Kroone C, Tieken C, Kocatürk B, et al. Tumor-expressed factor VII is associated with survival and regulates tumor progression in breast cancer. Blood Adv. 2023. PMID: 36920782. doi:10.1182/bloodadvances.2022008455

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。